NOX-E36 bietet vielversprechende Entwicklungsmöglichkeiten für Augenkrankheiten mit einem hohen Bedarf an gut verträglichen Therapien mit antifibrotischer Wirkung Die antifibrotische...
NOX-E36 presents promising opportunity for development in eye diseases with a high need for well-tolerated therapies with anti-fibrotic effect Anti-fibrotic mode of action of NOX-E36 was...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0066 | 4.73457675753 | 0.1394 | 0.18 | 0.126 | 1001690 | 0.15807168 | DE |
4 | 0.021 | 16.8 | 0.125 | 0.18 | 0.1174 | 461914 | 0.14822938 | DE |
12 | -0.0016 | -1.08401084011 | 0.1476 | 0.18 | 0.1128 | 451279 | 0.14656412 | DE |
26 | -0.104 | -41.6 | 0.25 | 0.26 | 0.1128 | 366588 | 0.15907953 | DE |
52 | -0.244 | -62.5641025641 | 0.39 | 0.47 | 0.1128 | 605118 | 0.24843529 | DE |
156 | 0.1042 | 249.282296651 | 0.0418 | 5.98 | 0.0398 | 313219 | 0.36140803 | DE |
260 | 0.1042 | 249.282296651 | 0.0418 | 5.98 | 0.0398 | 313219 | 0.36140803 | DE |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관